NEW YORK (GenomeWeb) – Invitae plans to offer 5,350,000 shares of its common stock at a price between $13 and $15 per share in its planned initial public offering, the firm said in an amended S-1 registration statement filed with the US Securities and Exchange Commission today.

Invitae had initially filed for an IPO last month, targeting $86 million in proceeds.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A federal grand jury has indicted Elizabeth Holmes and Ramesh Balwani for alleged wire fraud in conjunction with their activities at Theranos.

Nature News reports that some developers are nervous about GitHub's acquisition by Microsoft.

A direct-to-consumer genetic testing company sent out used spit kits, CNBC reports.

In PLOS this week: comparison of commercial bisulfite kits, new method to predict essential proteins, and more